Pharmaceutical Technology

JUNE 6, 2023

The rNPV model is a more conservative valuation measure that accounts for the risk of a drug in clinical development failing to progress. Pharma Mar Overview Pharma Mar discovers, develops and markets marine-derived drugs to treat cancer. Its development pipeline includes PM14 for solid tumors, among others.

Hormones 100

Hormones In-Vitro Genotype Bacteria 100

XTalks

JANUARY 22, 2021

Taiwan-based health and biotech company MedFluid has developed a rapid automated bacterial identification screening tool that can also tailor antibiotic treatments to an infection. It identifies bacteria using both genotypic and phenotypic assessments within 1.5

Bacteria 52

Bacteria In-Vitro Genotype Marketing 52

pharmaphorum

NOVEMBER 10, 2021

Success, then, will rely on an integrated response that focuses on surveillance, stewardship, and intervention accessibility across the spectrum of human, animal, and environmental health, said the report, which was commissioned to assess the progress of the 2014 National Strategy for Combating Antibiotic-Resistant Bacteria. Surveillance.

Medicine 105

Medicine Genomics Genome Genotype 105

XTalks

APRIL 3, 2024

This development, announced earlier this week, introduces a significant twist in the ongoing saga of the H5N1 virus , which has been affecting birds globally and in the US since early 2022. genotype in wild birds from November 2023. The detection of HPAI in dairy cows marks a concerning development for the US dairy industry.

Genotype 45

Genotype Contamination Bacteria Development 45

Delveinsight

DECEMBER 16, 2020

Caused by bacteria, viruses, and parasites, Sexually transmitted diseases (STDs) are a global health burden and it seems they are likely to maintain their status of being so in coming years also, primarily due to the lack of knowledge, and awareness. The medications can cure some of the STDs caused by bacteria, yeast, or parasites.

Bacteria 52

Bacteria Development Genotype Vaccination 52